CME Group Cash Flow Statement
NASDAQ: CMEFinanceInvestment Bankers/Brokers/ServiceUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CME Group free cash flow
In fiscal 2025, CME Group generated $4.28 billion of operating cash flow and spent $83.5 million on capital expenditures. That left free cash flow of $4.19 billion, a free-cash-flow margin of 64.3% of revenue. Free cash flow was up 16.6% from the prior year's $3.60 billion.
CME Group returned $3.93 billion to shareholders through dividends, equal to 94% of free cash flow. Free cash flow covered dividend payments 1.1 times.
Summary generated from market data by MetaCap's automated system. Methodology
CME Group cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 4.07B | 3.53B | 3.23B | 2.69B | 2.64B | 2.11B | 2.12B | 1.96B | 4.06B | 1.53B |
| Net Income growth (YoY) | +15.50% | +9.29% | +19.89% | +2.05% | +25.19% | -0.44% | +7.75% | -51.67% | +164.87% | +23.02% |
| Depreciation & Amortization | 107.50M | 115.10M | 126.00M | 134.90M | 147.80M | 153.20M | 158.60M | 118.70M | 113.00M | 129.20M |
| Stock-Based Compensation | 94.80M | 89.50M | 82.90M | 84.30M | 75.20M | 96.00M | 73.10M | 96.50M | 58.00M | 66.20M |
| Change in Working Capital | -59.90M | -30.10M | -23.00M | 41.00M | -47.80M | 78.40M | -16.90M | -24.00M | -74.50M | -36.60M |
| Operating Cash Flow | 4.28B | 3.69B | 3.45B | 3.06B | 2.40B | 2.72B | 2.67B | 2.44B | 1.75B | 1.73B |
| Capital Expenditures | -83.50M | -94.00M | -76.40M | -89.70M | -127.20M | -197.50M | -245.60M | -116.70M | -81.90M | -91.80M |
| Investing Cash Flow | 1.50B | -82.60M | 20.90M | -489.80M | 58.40M | -175.50M | -152.60M | -1.89B | 179.90M | 53.70M |
| Dividends Paid | -3.93B | -3.58B | -3.24B | -2.63B | -2.19B | -2.11B | -1.70B | -2.15B | -1.99B | -1.79B |
| Debt Issued | 740.60M | 0 | 0 | 741.00M | 0 | 0 | 0 | 1.19B | 0 | 0 |
| Financing Cash Flow | 56.51B | 5.08B | -48.34B | -25.38B | 69.91B | 47.25B | -2.34B | -1.08B | -1.99B | -1.62B |
| Net Change in Cash | 62.29B | 8.68B | -44.86B | -22.82B | 72.37B | 49.79B | -2.20B | -528.80M | -54.30M | 165.20M |
| Free Cash Flow | 4.19B | 3.60B | 3.38B | 2.97B | 2.28B | 2.52B | 2.43B | 2.32B | 1.67B | 1.64B |
This table shows 10 annual periods of CME Group's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CME's reporting calendar. What is a cash flow statement?